Hydration Pharmaceuticals Co. Ltd. Statistics
Want to see AU:HPC full AI Analyst Report?
Hydration Pharmaceuticals Co. Ltd. (HPC) Stock Statistics & Valuation Metrics
Total Valuation
Hydration Pharmaceuticals Co. Ltd. has a market cap or net worth of AUD 1.08M. The enterprise value is AUD 1.10M.
- Market Cap
- AUD 1.08M
- Enterprise Value
- AUD 1.10M
Share Statistics
Hydration Pharmaceuticals Co. Ltd. has 537,988,460 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 537,988,460
- Owned by Insiders
- 14.16%
- Owned by Institutions
- ―
Financial Efficiency
Hydration Pharmaceuticals Co. Ltd.’s return on equity (ROE) is -2.09 and return on invested capital (ROIC) is -229.32%.
- Return on Equity (ROE)
- -2.09
- Return on Assets (ROA)
- -1.35
- Return on Invested Capital (ROIC)
- -229.32%
- Return on Capital Employed (ROCE)
- -2.29
- Revenue Per Employee
- 852.64K
- Profits Per Employee
- -986.89K
- Employee Count
- 3
- Asset Turnover
- 1.17
- Inventory Turnover
- 2.96
Valuation Ratios
The current PE Ratio of Hydration Pharmaceuticals Co. Ltd. is -0.36. Hydration Pharmaceuticals Co. Ltd.’s PEG ratio is 0.00.
- PE Ratio
- -0.36
- PS Ratio
- 0.52
- PB Ratio
- 1.38
- Price to FCF
- -0.36
- Price to Operating Cash Flow
- -0.29
- PEG Ratio
- 0.00
Income Statement
In the last 12 months, Hydration Pharmaceuticals Co. Ltd. had revenue of 2.56M and earned -2.96M in profits. Earnings per share was -0.01.
- Revenue
- 2.56M
- Gross Profit
- -27.42K
- Operating Income
- -3.26M
- Pretax Income
- -2.85M
- Net Income
- -2.96M
- EBITDA
- -3.26M
- Earnings Per Share (EPS)
- -0.01
Cash Flow
In the last 12 months, operating cash flow was -3.10M and capital expenditures 0, giving a free cash flow of -3.10M billion.
- Operating Cash Flow
- -3.10M
- Free Cash Flow
- -3.10M
- Free Cash Flow per Share
- -0.01
Dividends & Yields
Hydration Pharmaceuticals Co. Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -276.93%
- Earnings Yield
- -274.81%
Stock Price Statistics
- Beta
- 1.06
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.01
- 200-Day Moving Average
- 0.01
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
Hydration Pharmaceuticals Co. Ltd. upcoming earnings date is Mar 01, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 31, 2026
- Next Earnings Date
- Mar 01, 2027
- Ex-Dividend Date
- ―
Financial Position
Hydration Pharmaceuticals Co. Ltd. as a current ratio of 2.83, with Debt / Equity ratio of 0.00%
- Current Ratio
- 2.83
- Quick Ratio
- 1.70
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.34
- Interest Coverage Ratio
- -43697.71
Taxes
In the past 12 months, Hydration Pharmaceuticals Co. Ltd. has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Hydration Pharmaceuticals Co. Ltd. EV to EBITDA ratio is -0.25, with an EV/FCF ratio of -0.22.
- EV to Sales
- 0.32
- EV to EBITDA
- -0.25
- EV to Free Cash Flow
- -0.22
- EV to Operating Cash Flow
- -0.22
Balance Sheet
Hydration Pharmaceuticals Co. Ltd. has AUD 442.73K in cash and marketable securities with AUD 0.00 in debt, giving a net cash position of AUD 442.73K billion.
- Cash & Marketable Securities
- AUD 442.73K
- Total Debt
- AUD 0.00
- Net Cash
- AUD 442.73K
- Net Cash Per Share
- AUD 0.00
- Tangible Book Value Per Share
- AUD 0.00
Margins
Gross margin is 0.86%, with operating margin of -126.66%, and net profit margin of -115.95%.
- Gross Margin
- 0.86%
- Operating Margin
- -126.66%
- Pretax Margin
- -115.93%
- Net Profit Margin
- -115.95%
- EBITDA Margin
- -126.66%
- EBIT Margin
- -126.66%
Scores
- Smart Score
- 5
- AI Score
- 43
